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Introduction: Orofacial pain and dysfunction include a broad range of disturbances
among which pain and insomnia are some of the most common complaints. Sleep
strengthens physiological and psychological resilience and is an absolute requirement
for health. Insomnia is a common symptom or sleep disorder, yet data on its prevalence
is sparse. Here we extracted data from the insomnia severity index which was part of the
web-based interdisciplinary symptom evaluation (WISE) tool given to a large sample of
patients seeking care at an orofacial pain unit for analyzing insomnia prevalence in this
clinical population.
Material and methods: Anonymized data were available from 952 patients who
consulted the Orofacial Pain Unit at the Center of Dental Medicine, University of Zurich,
Zurich, Switzerland between January 2017 and December 2018. Prevalence data for
insomnia stratified by gender and 10 age groups (decades) were calculated. The
distribution of four insomnia severity grades was determined, also stratified by age
and gender.
Results: 952 patients (290 men: 30.5%) with a mean age of 44.8 ± 17.4 years
completed a WISE. Three hundred and fifty-two (37.0%) patients with a mean age of
45.8 ± 16.7 years positively responded to a screening question for insomnia and/or
hypersomnia. Insomnia was severe in women from the 2nd to 8th decade, ranging
from 4.3% (3rd decade) to 14.5% (6th decade), and moderately severe from the 2nd
to 9th decade, ranging from 18.8% (6th decade) to 27.8% (2nd decade). In men, severe
insomnia was present from the 3rd to 7th decade, ranging from 2.3% (7th decade) to
4.4% (4th decade) and moderately severe insomnia from the 3rd to 7th decade, ranging
from 4.6% (7th decade) to 12.2% (5th decade).
Conclusions: This is the first study reporting on insomnia in a large sample of patients
seeking care at an orofacial pain unit. One in three patients reported some form of
sleep disturbances, which for almost half of them was moderate to severe insomnia.
The gender ratio was almost equal throughout adulthood, yet younger and older women
were more frequently affected and experienced higher insomnia severity than men.
Keywords: orofacial pain, sleep, insomnia, dysfunction, prevalence, insomnia severity index, sleep questionaire,
epidemiology
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INTRODUCTION
Orofacial disorders can be painful or painless and with or
without functional impairment. They include a broad range of
disturbances with heterogeneous etiologies in dental, mucosal,
musculoskeletal, and neuronal tissues. These conditions can
be summarized under the umbrella term orofacial pain and
dysfunction (OPD). According to community based surveys, the
prevalence of OPD varies greatly, from 5 to 57% depending on
the study period, population, location, and other factors (1).
Chronic OPD affect women more frequently (2, 3). Impaired
sleep and insomnia are commonly reported by patients with
OPD (4, 5).
Healthy sleep was recently defined in a joint consensus
statement of the American Academy of Sleep Medicine
and Sleep Research Society as “adequate duration, good
quality, appropriate timing and regularity, and the absence
of sleep disturbances or disorders” (6). Sleep strengthens
physiological and psychological resilience (7). Sleep regulation
has a sleep-promoting, homeostatic component and a circadian
component (8, 9). When a person sleeps or is awake (circadian
sleep propensity) characterizes the individual chronotype.
This is in part determined by genetics, and modified by
age, activity, and light exposure (10–12). In the long-term,
disturbed sleep is associated with multiple adverse health
outcomes, including cardiovascular, metabolic, and mental
TABLE 1 | Patient numbers (N) and distribution in the global sample stratified per decade and by gender.
10–19 20–29 30–39 40–49 50–59 60–69 70–79 80–89 90–99 Total
M W M W M W M W M W M W M W M W M W
N 20 49 36 104 64 110 60 124 53 123 35 87 19 60 3 4 0 1 952
Distribution (%) 2.1 5.1 3.8 10.9 6.7 11.6 6.3 13.0 5.6 12.9 3.7 9.1 2.0 6.3 0.3 0.4 0 0.1 100%
FIGURE 1 | Age and gender distribution of the global sample of 952 patients experiencing orofacial pain and dysfunction (OPD).
health disturbances (13–16). The most common sleep disorder
is insomnia, defined as “a persistent difficulty with sleep
initiation, duration, consolidation, or quality that occurs despite
adequate opportunity and circumstances for sleep” (17). Hence
insomnia is vague term describing the phenotypes of several
sleep disturbances with different underlying etiologies. Different
studies of non-clinical populations worldwide assessments have
reported an insomnia prevalence from 5 to 50%, mostly with
a predominance in females (18–25). For insomnia evaluation,
subjective assessment is considered the gold standard and has
been recommended for the evaluation of patients with OPD (26–
29). Numerous relatively brief self-reported questionnaires have
been developed and validated to detect and quantify insomnia
or sleep-related impairment in different populations (30, 31).
The Patient Health Questionnaire 9 (PHQ-9) commonly used
in primary care to screen for depression includes the item
“trouble falling or staying asleep or sleeping too much” that
screens for insomnia and/or excessive daytime sleepiness (32). In
addition to screening, the insomnia severity index (ISI) also offers
some quantification. (33, 34). This brief self-report questionnaire
consists of seven items to be rated on a five-point Likert scale,
ranging from 0 (none) to 4 (very severe). The items are difficult
initiating and maintaining sleep; awaking early; dissatisfaction
with current sleep patterns; sleep related impairment of quality
of life (noticed by others), worries or distress, and interference
with daytime functioning. Total scores range from 0 to 28,
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whereas higher scores indicate more severe insomnia. Four
insomnia grades have been categorized (scores in brackets): not
clinically significant (0–7), subthreshold (8–14), moderate (15–
21), and severe (22–28).Moderate to severe grades are considered
clinically relevant.
For this paper, we used data collected by the web-based
interdisciplinary symptom evaluation (WISE) which is a new
self-report instrument designed to obtain computer guided
patient information related to orofacial disorders of diverse
etiologies and comorbid conditions (35). The WISE combines a
symptom-burden checklist with various validated psychometric
in-depth questionnaires serving as case-finding instruments, one
of them being the ISI. Insomnia associated with chronic pain
is phenotypically similar to primary insomnia (36). Yet the
interaction of sleep and pain is poorly understood (37–39). High
quality prevalence data of insomnia in persons suffering from
pain (including OPD) is sparse (40, 41). In this work, we aimed
at identifying the prevalence of insomnia in a large sample of
patients seeking care at an orofacial pain unit.
MATERIAL AND METHODS
Anonymized data were extracted from WISE completed by
952 patients who consulted the Orofacial Pain Unit at the
Center of Dental Medicine, University of Zurich, Zurich,
Switzerland between January 2017 and December 2018. Patients
completed the WISE prior to their first appointment. The
symptoms of our study population varied from painless yet
burdening functional disorders to painful conditions with widely
varying orofacial pain location, quality, time pattern, and
related disability.
For questionnaires to be analyzed, patients must have clicked
a checkbox indicating their consent that their anonymized data
can be used for research. According to Swiss law, the analysis of
strictly anonymized data does not require approval by an ethics
committee. We compared the clinic population that completed
the WISE with the clinic population that did not complete it or
did not give consent to use the data for research.
Using the software SPSS version 23, we calculated prevalence
data for insomnia stratified by gender and age group (decades).
The distribution of four insomnia severity grades was determined
stratified by age and gender. Means were compared between
genders using an independent sample t-test with Welch’s
correction, since equality of variance was not assumed.
RESULTS
The population of the 952 patients completing the WISE (global
sample) had a mean age of 44.8± 17.4 years (range: 10–90 years;
44.1 years). It consisted of 290 men (30.5%) with a mean age
of 44.3 ± 16.5 years (range: 12–84 years; median 43 years) and
662 women (69.5%) of 45.0 ± 17.8 years (range: 10–90 years;
median 46 years). The gender ratio therefore was 1:2.3.Mean ages
between genders did not differ (p > 0.05) (Table 1; Figures 1, 2).
FIGURE 3 | Box plots representing the age distribution by gender of the 682
patients who did not complete the WISE or did not consent to data use. Star
symbol (*) indicates mean.
FIGURE 2 | Box plots representing the age distribution by gender of the 952 patients experiencing orofacial pain and dysfunction. Star symbol (*) indicates mean.
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TABLE 2 | Patient numbers (N), distribution, proportion within gender, and prevalence of insomnia stratified by ISI categories and by gender.
Clinically relevant
Not clinically significant Subthreshold Moderate Severe Total
M W T M/W M W T M/W M W T M/W M W T M/W M W T M/W
N 17 39 56 41 105 146 29 81 110 10 30 40 97 255 352
Distribution (%) 4.8 11.1 15.9 1:2.3 11.6 29.8 41.5 1:2.6 8.2 23 31.2 1:2.8 2.8 8.6 11.4 1:3 27.5 72.5 100 1:2.6
Proportion (%) within
gender
17.5 15.3 1.1:1 42.2 41.2 1:1 29.9 31.8 1:1.1 10.3 11.8 1:1.2
Prevalence (%) (952
pts)
1.8 4.1 5.9 1:2.8 4.3 11.0 15.3 1:2.6 3.0 8.5 11.5 1:2.8 1.1 3.2 4.3 1:2.9 10.2 26.8 37 1:2.6
Prevalence (%) within
gender (290M, 662W)
5.9 5.9 1:1 14.1 15.9 1:1.1 10 12.2 1:1.2 3.5 4.5 1:1.3
M/W, ratio men to women; pts, patients.
FIGURE 4 | Box plots representing the age distribution by gender of the 352
patients responding positively to the screening question on insomnia and/or
hypersomnia. Star symbol (*) indicates mean.
The population of the 682 patients not completing the WISE or
not giving consent had a mean age of 48.3 ± 18.3 years (range:
11–89 years; 48 years) and consisted of 213 men (31.2 %) with
a mean age of 46.9 ± 17.4 years (range: 13–89 years; median 46
years) and 469 women of 48.9 ± 17.5 years (range: 11–89 years;
median 49 years) (Figure 3). The gender ratio therefore was 1:2.2.
Mean ages between the two populations did not differ (p > 0.05).
Three hundred and fifty-two (37.0%) patients with a mean age
of 45.8 ± 16.7 years (range: 13–88 years; 45.5 years) reported
“trouble falling or staying asleep or sleeping too much” on the
WISE checklist and the ISI was presented to these. The 97
men (10.2%) in this group had a mean age of 43.5 ± 13.8
years (range: 17–80 years; median 42 years) and the 255 women
(26.8% of global sample) of 46.7 ± 17.6 years (range: 13–88
years; median 47 years). The gender ratio therefore was 1:2.6.
Neither age nor gender distribution differed between patients
with insomnia and all patients (p > 0.05) (Table 2; Figures 2, 4).
For the four ISI categories, the distribution of men and women,
the gender ratio (in round brackets), and the proportions within
each gender [in square brackets] were as follows: not clinically
significant 15.9% (1:2.3) [1.1:1], subthreshold 41.5% (1:2.6) [1:1],
moderate 31.2% (1:2.8) [1:1.1], and severe 11.4% (1:3) [1:1.2]
(Table 2; Figure 5).
The distribution of ISI scores, its gender ratios (in brackets),
and its ratios within each gender [in square brackets] according to
increasing severity grades were: 5.9% (1:2.8) [1:1], 15.3% (1:2.6)
[1:1.1], 11.5% (1:2.8) [1:1.2] to 4.3% (1:2.9) [1:1.3] (Table 2). The
mean ISI score was 13.8 ± 6.0 (men 13.4 ± 6.2; women 13.9 ±
6.2 (Figure 6).
The patients responding positively to the screening question
on insomnia and/or hypersonia are listed in Table 3, sorted by
distribution and proportion within gender per decade and by
gender. This table also lists the prevalences according to all
patients, to gender groups, and to gender of each decade in the
global sample. The prevalence data in this table and Figure 7
reveal that 1.9% of teenagers and adolescents experienced
insomnia. Among males, insomnia was most prevalent in the
4th and 5th decade (2.7 and 2.4%, respectively) while prevalence
peaked in women in the 5th and 6th decades (5.4 and 5.3%,
respectively). The ratio of the prevalence within gender and
within gender per decade (in brackets) was: 2nd 1:3.4 (1:3.3),
3rd 1:1 (1.2:1), 4th 1.5:1 (1.1:1), 5th 1:1 (1:1.1), 6th 1:1.2
(1:1.1), 7th 1:1.7 (1:1.6), 8th 1:3.9 (1:2.7), and 9th 1:1.7 (1:2.6)
(Table 3; Figure 7).
Figure 8 shows the distributions of the three ISI categories
(scores ≥ 8) per decade and by gender. The severe grade was
present in women from the 2nd to 8th decade, ranging from
4.3% (3rd decade) to 14.5% (6th decade) and moderately severe
from the 2nd to 9th decade, ranging from 18.8% (6th decade) to
27.8% (2nd decade). In men, severe insomnia was present from
the 3rd to 7th decade, ranging from 2.3% (7th decade) to 4.4%
(4th decade) and moderately severe from the 3rd to 7th decade,
ranging from 4.6% (7th decade) to 12.2%(5th decade).
DISCUSSION
In this paper, we analyzed complaints of insomnia in a large
sample of 952 patients seeking care at an orofacial pain unit,
covering a broad age range. A first main study finding was that
37.0% of those patients reported sleep disturbance in the form
of insomnia and/or excessive daytime sleepiness (hypersomnia).
Secondly, women across a broader age range than men were
affected by insomnia. Thirdly, when taking into consideration
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FIGURE 5 | Distribution of insomnia severity index (ISI) scores stratified by gender. Background colors reflect ISI categories: not clinically significant (yellow),
subthreshold (orange), moderate (pink), severe (red).
FIGURE 6 | Box plots representing the distribution of the Insomnia Severity
Index (ISI) scores reported by patients experiencing insomnia by gender. Star
symbol (*) indicates mean.
the proportions within gender, the ratios of insomnia between
men and women were almost equal in young and middle-aged
adults, yet higher in female teenagers and adolescents as well as
older women.
For the three populations, namely the global sample
completing the WISE, the sample that did not complete the
WISE or did not consent to data use, and the patients reporting
insomnia, the mean ages of 44.8 ± 17.4, 48.3 ± 18.3, and 45.8 ±
16.7 years, respectively, were not statistically different (p > 0.05)
(Table 1; Figures 1, 2). Also the gender ratios of 1:2.3, 1:2.2, and
1:2.6, respectively, were similar among the three populations.
This mean age and the gender ratio corresponds to a patient
sample of our clinic previously analyzed with a different study
question (42). The unequal gender distribution of the global
sample is important and can be accounted for by calculating
within gender ratios for men and women. Accordingly, focusing
on the ratios of the proportions within each gender in Table 2,
they were almost equal (1:1.1 for the lower three severities and
1:1.2 for the highest severity), meaning that the proportion of
men and women in all ISI categories hardly differed. Yet, with
increasing severity, the prevalence of insomnia slightly increased
in women compared to men (from 1.1:1 to 1.1:3), although
the mean scores did not significantly differ between gender
(Figure 6). Among all patients reporting insomnia, moderate and
severe grades were reported by almost half (42.6%), representing
a combined prevalence of 15.8% of these two categories. This
means that one in six patients suffered from clinically relevant
insomnia (Table 2; Figure 5). If the threshold criterion of an ISI
score of 8 were considered, this number would double to 1 in
three patients (31.1%).
The proportions within each gender had also relatively
balanced ratios in the population of the 3rd, 5th, 6th, and
9th decade (Table 3). Men experienced proportionately more
insomnia only in the 4th decade (1.5:1), whereas a reverse
pattern was seen in the 2nd, 7th, and 8th decade with values
of 1:3.4, 1:1.7 and 1:3.9, respectively. This means that younger
and older women experienced insomnia disproportionately more
than men (Figure 7).
The distribution of the three ISI categories (scores ≥
8) per decade and by gender is displayed in Figure 8.
While ISI scores in men peaked in the 4th decade and
gradually declined thereafter, a reverse pattern was observed
in adult women with a trend toward increasing scores with
older age. In other words, with increasing age, women
tended to have only slightly more insomnia yet of higher
severity. Notably, severe insomnia was not reported by
women in the 9th decade. On the opposite, the largest
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TABLE 3 | Patient numbers (N), distribution, proportion within gender, and prevalence of patients responding positively to the screening question on insomnia and/or
hypersomnia, stratified per decade and by gender.
10–19 20–29 30–39 40–49 50–59 60–69 70–79 80–89
M W T M W T M W T M W T M W T M W T M W T M W T
N 2 16 18 14 33 47 26 41 67 23 51 74 19 50 69 9 35 44 3 26 29 1 3 4
Distribution (%) 0.6 4.5 5.1 4.0 9.4 13.4 7.4 11.6 19.0 6.5 14.5 21.0 5.4 14.2 19.6 2.6 9.9 12.5 0.9 7.4 8.2 0.3 0.9 1.1
M/W M/W M/W M/W M/W M/W M/W M/W
Proportion (%) within
gender
2.1 6.3 1:3 14.4 12.9 1.1:1 26.8 16.1 1.7:1 23.7 20.0 1.2:1 19.6 19.6 1:1 9.3 13.7 1:1.5 3.1 10.2 1:3.3 1.0 1.2 1:1.2
Global prevalence (%)
(952 pts)
0.2 1.7 1:8.5 1.5 3.5 1:2.3 2.7 4.3 1:1.6 2.4 5.4 1:2.3 2.0 5.3 1:2.7 0.9 3.7 1:4.1 0.3 2.7 1:9 0.1 0.3 1:3
Prevalence (%)
within gender (290M,
662W)
0.7 2.4 1:3.4 4.8 5.0 1:1 9.0 6.2 1.5:1 7.9 7.7 1:1 6.6 7.6 1:1.2 3.1 5.3 1:1.7 1.0 3.9 1:3.9 0.3 0.5 1:1.7
Prevalence (%) within
gender per decade
(Table 1)
10 32.7 1:3.3 38.9 31.7 1.2:1 40.6 37.3 1.1:1 38.3 41.1 1:1.1 35.9 40.7 1:1.1 25.7 40.2 1:1.6 15.8 43.3 1:2.7 33.3 75 1:2.6
M/W, ratio men to women; pts, patients. Male to female ratios are highlighted in bold.
FIGURE 7 | Prevalence (%) of insomnia and/or hypersomnia, stratified by men (M), and women (W) as well as by age group (decades).
proportion of scores ≥ 8 was reported by female teenagers and
adolescents, yet mainly due to the relatively high percentage of
subthreshold insomnia.
Comparing our results to other studies is difficult due
to the restricted use of the ISI or other validated tools for
analyzing insomnia in large cohorts. Wemostly identified studies
using other types of self-reports that were not validated for
grading insomnia severity. Hence, insomnia prevalence’s ranging
from 5 to 50% reported in those works have to be interpreted with
caution (18–25). An exception was the report by Jank et al. who
employed the ISI for analyzing insomnia in a mixed group with
and without pain complaints (40). In this sample of 570 patients
from Austria, insomnia prevalence was 29.1%, with 55 subjects
(9.6%) complaining of clinically relevant insomnia. The mean
age of this population was slightly higher (50.8 ± 18.7 years).
Gender ratios were not calculated. Another study investigated
insomnia in 481 Korean patients complain of low back pain (43).
The mean age of the study sample was 58.2± 16.7 (range 20–90).
The gender ratio was 1:1.5 compared to 1:2.3 in our sample. The
mean ISI score was 7.5 ±7.1 and thus much lower compared to
13.8 ± 6 observed here. The distribution of insomnia among the
four ISI categories compared to ours (in brackets) in ascending
severity was: 57.0 (5.9), 23.0 (15.3), 14.7 (11.5), and 5.3 (4.3).
Thus, the proportion of clinically relevant insomnia was similar.
However, no gender ratios were provided that would allow an
estimation of the gender related distribution. In 6,205 Swedish
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FIGURE 8 | Distributions of Insomnia Severity Index (ISI) categories including only scores ≥ 8 per decade among 97 men (M) and 255 women (W).
individuals older than 65 years with no, subacute and chronic
pain, the proportion of moderate and sever insomnia was 35.1
and 4.3%, respectively (41). In this cohort, a mean ISI score of 10
was observed in the group experiencing subacute pain (N = 510)
and 10.9 in the chronic pain group (N = 2,790), both of which are
lower than the mean ISI score of 13.8 identified in our sample of
OPD. None of the above-mentioned studies analyzed insomnia
severity across the life span.
Our analysis has some noteworthy limitations: it is cross-
sectional, i.e., insomnia was captured at one point in time.
Hence, the results do not allow inferring potential time-related
dynamics. As only few studies report high quality prevalence data
of insomnia in persons suffering from pain (40, 41), the inclusion
of age and gender paired controls would be an interesting aspect
to be considered in future studies. As we aimed at reporting
insomnia in a representative sample of our clinic population, we
also included persons aged 10–20 years, even though the ISI is
not specifically validated for this age group.
Also, no statements can be made regarding possible
associations of insomnia complaints with the patients’
chief complaints and/or diagnoses, co-morbidities (e.g.,
psychopathologies) or other confounding factors (e.g.,
snoring), since we did not take these aspects into account.
Specifically, the assessment of somatic and/or psychological co-
morbidities known to influence sleep (e.g., tinnitus, wide-spread
pain, anxiety, depression, distress, catastrophic rumination,
neuroticism, obsessive-compulsive, or post-traumatic stress
disorder) would have offered information on possible cause-
effect relationships, yet this effort was outside the scope of this
work. Finally, insomnia could also be secondary to the use of
medication or substance use, both of which were not controlled
as a co-factor in the study.
Nonetheless, future research should focus on cross-sectional
and longitudinal interactions of insomnia, psychopathology and
other associated factors in patients with OPD (44).
CONCLUSIONS
This is the first study reporting on insomnia in a large sample
of patients referred to an orofacial pain unit. 37.0% of patients
responded positively to a screening question for insomnia and/or
hypersomnia. For almost half of them, insomnia was moderate
to severe. The gender ratio was almost equal throughout
adulthood, yet younger and older women were more affected and
experienced higher severity than men.
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